Clinical value of liver scans

Area of Science:

• Nuclear Medicine
• Diagnostic Imaging
• Hepatology

Background:

• Liver scans are diagnostic tools used to assess liver function and detect abnormalities.
• The clinical utility of technetium sulfacolloid liver scans in patient care requires evaluation.

Purpose of the Study:

• To assess the contribution of technetium sulfacolloid liver scans to patient care.
• To determine the usefulness and impact of liver scans on diagnosis and management plans.

Main Methods:

• Evaluation of 200 consecutive patients (100 public, 100 private hospital).
• Analysis of problem-oriented records to assess scan impact on problem assessment and diagnostic/management plans.
• Categorization of patient conditions into intrinsic hepatobiliary diseases, extrahepatic malignancy, and miscellaneous conditions.

Main Results:

• For intrinsic hepatobiliary diseases, scans were useful in 5/30 but misleading in 4/30 patients; other methods provided specific diagnoses.
• For extrahepatic malignancy (123 patients), scans were useful in 95, primarily due to chemotherapy protocols; 18% of positive scans lacked other clinical evidence.
• Scans were useless in 37/47 (79%) of miscellaneous conditions, and misleading in 3, impairing patient care.

Conclusions:

• Technetium sulfacolloid liver scans represent an overutilization for primary liver/biliary diseases, as specific diagnoses are better achieved through other methods.
• Scans have utility in monitoring chemotherapy for extrahepatic malignancies but do not provide definitive diagnoses.
• The diagnostic value of liver scans is limited, and they can occasionally mislead clinicians, negatively impacting patient care.